Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

for
Hematologic Disorder, Bleeding Disorder,
Location: Scarborough ME, Providence RI, Hartford CT,
Sponsor: American Thrombosis and Hemostasis Network

Sex: All

Age: 0+

Code: NCT04398628

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial

for
Postoperative Restriction, Midurethral Sling, Mesh,
Location: Iowa City IA
Sponsor: University of Iowa

Sex: Female

Age: 18 - 70+

Code: NCT06840093

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Carbon Dioxide (CO2) Chemosensitivity and SUDEP

for
Epilepsy, SUDEP
Location: Iowa City IA
Sponsor: University of Iowa

Sex: All

Age: 18 - 70+

Code: NCT04134754

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW

for
Chronic Total Occlusion of Artery of the Extremities
Location: Wilmington DE, Cocoa FL, Dearborn MI, Chattanooga TN,
Sponsor: Versono Medical Ltd

Sex: All

Age: 18 - 70+

Code: NCT06492733

Recruiting

Follow-up Visit of High Risk Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Philadelphia PA, Durham NC, Cleveland OH, Detroit MI,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 1 - 2

Code: NCT00009633

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05633654

Phase3, Recruiting

Breast Cancer PSMA PET

for
Triple Negative Breast Cancer
Location: Iowa City IA
Sponsor: Ahmad Shariftabrizi

Sex: Female

Age: 18 - 70+

Code: NCT06586047

Early_phase1, Recruiting

STRIDE Biorepository

for
Anemia, Sickle Cell
Location: Bronx NY, New York NY, Brooklyn NY, Hackensack NJ,
Sponsor: Emory University

Sex: All

Age: 15 - 40

Code: NCT02843347

Recruiting

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

for
Infant, Extremely Premature, Obstetric Labor, Premature,
Location: Boston MA, The Bronx NY, Hackensack NJ, Burlington VT,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0 - 1

Code: NCT05685745

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Gloucester MA, Beverly MA, Peabody MA, Burlington MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Westbury NY, Fresh Meadows NY, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

for
Acute Kidney Injury
Location: Langhorne PA, Bethlehem PA, Norfolk VA, Cleveland OH,
Sponsor: SeaStar Medical

Sex: All

Age: 18+

Code: NCT05758077

Recruiting

Behavioral Economic & Staffing Strategies in the ICU

for
Implementation Science, Delirium, Critical Illness,
Location: Columbus OH, Iowa City IA, Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT06184945

Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Boston MA, New Haven CT, Mineola NY, New York NY,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Treatment Study of AV Node Reentry Tachycardia

for
Supraventricular Tachycardia
Location: Washington DC, Hollywood FL, Louisville KY, Madison WI,
Sponsor: Jeffrey Moak

Sex: All

Age: 0 - 21

Code: NCT04232371

Recruiting

Stroke Thrombectomy and Aneurysm Registry

for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Portsmouth NH, Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Medical University of South Carolina

Sex: All

Age: 1 - 70+

Code: NCT04994756

Recruiting

The Pediatric Anesthesia Quality Improvement Project

for
Surgery, Anesthesia, Children
Location: Boston MA, New York NY, Philadelphia PA, Wilmington DE,
Sponsor: The Society for Pediatric Anesthesia

Sex: All

Age: 0 - 21

Code: NCT00674388

Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa